PatternsRadar
Sign in

COHANCECohance Lifesciences Limited

NSE
462.30INR+2.85 (+0.62%)Close · 20 Nov 2026
6 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹17,687 CrMarket cap
373.4P/E (TTM)
46.2%Delivery

Filings & corporate actions

28 results filed
CSV
Next results · Q3 FY27
Expected 6 Feb 2027 – 13 Feb 2027
Estimate: filed 37–44 days after quarter end, last 5 times
Dividend
₹6.00 per share · last 9 Sept 2022
2026
  • 6 NovresultsResults · Q2 FY27 · consolidated and standalone+1.9%NSE
  • 15 OctshareholdingShareholding · 30 Sept 2026+3.2%NSE
  • 5 AugresultsResults · Q1 FY27 · consolidated and standalone+2.2%NSE
  • 27 JulresultsResults · Q4 FY26 · standalone-0.5%NSE
  • 17 JulshareholdingShareholding · 30 Jun 20260.0%NSE
  • 17 JulresultsResults · Q2 FY26 · consolidated and standalone+2.0%NSE
  • 12 MayresultsResults · Q4 FY26 · consolidated and standalone-5.8%NSE
  • 21 AprshareholdingShareholding · 31 Mar 2026-2.2%NSE
  • 12 FebresultsResults · Q3 FY26 · consolidated and standalone-10.0%NSE
  • 21 JanshareholdingShareholding · 31 Dec 2025-4.0%NSE

Reaction to results · all yearsrose on day 0 in 11 of 26 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY276 Nov 2026+1.9%+5.5%—0.5×
Q1 FY275 Aug 2026+2.2%+3.4%+7.3%11.0×
Q4 FY2612 May 2026-5.8%-13.3%-12.6%0.7×
Q3 FY2612 Feb 2026-10.0%-12.9%-16.3%7.3×
Q2 FY2612 Nov 2025-8.8%-15.7%-23.1%6.9×
Q1 FY2613 Aug 2025-7.3%-10.3%-0.1%5.7×
Q4 FY2528 May 2025-3.8%-4.1%-9.6%1.4×
Q3 FY2513 Feb 2025-2.7%+9.5%+1.2%0.9×
Q2 FY2513 Nov 2024+1.0%+2.5%+0.5%1.1×
Q1 FY259 Aug 2024+4.7%+0.2%+22.8%1.4×
Q3 FY246 Feb 2024+1.2%+6.7%+7.3%2.0×
Q2 FY2410 Nov 2023+1.2%+2.2%+19.8%0.2×
Q1 FY248 Aug 2023+0.6%+6.4%+5.2%2.1×
Q4 FY2326 May 2023+0.3%+0.5%+2.4%0.7×
Q3 FY237 Feb 2023-0.2%-1.3%-2.4%2.1×
Q2 FY239 Nov 2022+0.4%+5.2%+4.3%6.1×
Q1 FY239 Aug 2022-8.6%-5.9%-0.6%2.7×
Q4 FY2210 May 2022-6.0%-7.8%-13.5%1.7×
Q3 FY229 Feb 2022-5.1%-3.8%-10.6%0.8×
Q2 FY226 Nov 2021-1.1%+1.7%-0.3%2.4×
Q1 FY2213 Aug 2021+3.1%+0.2%-0.7%0.7×
Q4 FY219 Jun 2021-5.1%-2.5%-4.9%4.3×
Q3 FY2111 Feb 2021-3.1%-2.0%-6.4%2.5×
Q2 FY2131 Oct 2020-4.4%+5.1%+20.9%2.1×
Q1 FY2118 Aug 2020-5.9%+1.2%+10.3%2.6×
Q4 FY2019 Jun 2020+16.3%+41.7%+70.9%8.1×
Average-1.7%+0.5%+2.9%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY-14.2%
Profit YoY-79.5%
Interest cost YoY+19.2%
Revenue QoQ+12.9%
Profit QoQ—
CAGR2Y3Y4Y5Y6Y7Y
Revenue—+16.6%+10.7%+13.4%——
Profit—-52.1%-42.4%-34.7%——

Key data

Open455.00
Day range453.20 – 465.65
52-week range266.70 – 624.00
From 52w high-25.9%
RSI (14)53.6
ATR (14)17.01
Volume3.19L
Avg volume (20D)6.25L
Rel volume0.51×
Volatility (1Y)48.4%
Turnover₹14.7Cr
Traded value (NSE)₹14.7Cr
VWAP461.11
SMA 50 / 200452.15 / 412.35
Price band20%

Delivery percentage

Latest · 20 Nov 202646.2%
20-day avg40.7%
1-year avg44.0%
Percentile (own history)25th
Range5.5–100.0%
Sessions1,656

Over the last 20 sessions COHANCE settled 40.7% of its traded quantity, which is ordinary for an NSE equity. Its one-year average is 44.0%, so recent sessions are running 3.3 points lower than usual. The latest session ranks higher than 25% of the 1,656 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.00%
Dividend, trailing 12M₹0.00
Paid every year for0 yr
Shareholders93.8K · -5.3% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹223.4Cr
Last bulk buy9 days ago

Performance returns

1D1W1M3M6M1Y
Price+0.62%+0.81%+1.86%-2.79%+10.10%-24.89%

Valuation

Market cap₹17,687 Cr
Market cap (NSE)₹17,687 Cr
Free-float cap₹7,521 Cr
P/E (TTM)373.4
P/E (NSE)293.5
EPS (TTM)1.24
P/B4.5
Net margin (TTM)2.3%
Other income / PBT420.6%
ROE1.2%
Debt / equity0.06
Shares outstanding38.26Cr
Listed9 Mar 2020

Ownership

Promoter57.48%
Promoter Δ QoQ-0.01 pp
Public42.52%
FII7.71%
DII18.86%
Pledged94.56%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)544.6619.1422.3476.7
YoY chg+77.3%+54.0%-23.1%-14.2%
Net profit (₹ Cr)29.08.3(45.2)2.3
YoY chg-65.2%-78.5%-197.4%-96.6%
Net margin5.3%1.3%-10.7%0.5%
EPS0.960.50-0.650.38

Shareholding over time

By quarter

30 Sept 2026 · promoter 57.48% · public 42.52%
30 Sept 2021: promoter 60.00%31 Dec 2021: promoter 60.00%31 Mar 2022: promoter 60.00%30 Jun 2022: promoter 60.00%30 Sept 2022: promoter 60.00%31 Dec 2022: promoter 60.00%31 Mar 2023: promoter 60.01%30 Jun 2023: promoter 60.00%30 Sept 2023: promoter 60.00%31 Dec 2023: promoter 60.00%31 Mar 2024: promoter 50.10%30 Jun 2024: promoter 50.10%30 Sept 2024: promoter 50.10%31 Dec 2024: promoter 50.10%31 Mar 2025: promoter 50.10%9 May 2025: promoter 66.41%30 Jun 2025: promoter 66.41%30 Sept 2025: promoter 57.49%31 Dec 2025: promoter 57.49%31 Mar 2026: promoter 57.49%30 Jun 2026: promoter 57.49%30 Sept 2026: promoter 57.48%
2021-092026-09
  • Promoter
  • Public and others
Promoter
57.48%
Public
42.52%
Promoter change
-0.01 pp
Filed
15 Oct 2026
FII
7.71%
DII
18.86%
Promoter pledged
94.56%

Who the public is

Mutual funds
16.93%

-1.28 pp QoQ

Insurance
1.78%

+0.01 pp QoQ

FPI
7.71%

+1.21 pp QoQ

Retail ≤ ₹2L
7.25%

-0.14 pp QoQ

HNI > ₹2L
0.24%

-0.08 pp QoQ

NRI
0.55%

-0.01 pp QoQ

Bodies corporate
7.53%

+0.21 pp QoQ

Shareholders
93,846

-5.3% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
BEHRYANDA LIMITEDPromoter · Corporate33.34%
JUSMIRAL HOLDINGS LIMITEDPromoter · Corporate24.15%
JASUB PROPERTY HOLDINGS LLPCorporate3.84%
SBI MNC FUNDMutual fund3.73%
ICICI PRUDENTIAL HEALTHCARE FUNDMutual fund3.68%
DSP FLEXI CAP FUNDMutual fund2.90%
JASTI PROPERTY AND EQUITY HOLDINGS PRIVATE LIMITEDCorporate2.51%
AMANSA HOLDINGS PRIVATE LIMITEDFPI2.18%
HDFC TRUSTEE COMPANY LIMITED - HDFC TAX SAVERFUNDMutual fund2.16%
SBI LIFE INSURANCE CO. LTDInsurance1.75%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 17 Feb 2021 CSV
Financial yearPaymentsDeclaredAdjusted
FY2022-232₹8.00₹8.00
FY2021-222₹4.00₹4.00
FY2020-211₹1.00₹1.00
Ex-dateRecord dateDeclaredAdjusted
9 Sept 2022—₹6.00₹6.00
13 May 2022—₹2.00₹2.00
15 Feb 2022—₹3.00₹3.00
13 Aug 2021—₹1.00₹1.00
17 Feb 2021—₹1.00₹1.00

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

Insider trades

Insiders net, 30d
₹0
Insiders net, 90d
₹0
Promoters net, 90d
₹0
Insider buyers, 90d
0
Last promoter buy
none on record
Disclosures on record
11
7 open-market of the newest 11
By year
BroadcastPersonSideSharesValuePriceHolding before → afterStakeRegulation
14 Aug 2023PADMAJA J.A.SRelativeSell28.0K₹1.4Cr501.7728.0K → —0.00%7(2)told 14 Aug 2023
17 Feb 2023PADMAJA J.A.SRelativeSell7.0K₹33.8L482.2535.0K → 28.0K0.01%-0.00 pp7(2)told 17 Feb 2023
2 Sept 2020PADMAJA J.A.SRelativeBuy5.0K₹32.0L640.6412.5K → 17.5K0.01%+0.00 pp7(2)told 1 Sept 2020
31 Aug 2020PADMAJA J.A.SRelativeBuy2.5K₹17.2L688.1510.0K → 12.5K0.01%+0.00 pp7(2)told 29 Aug 2020
27 Aug 2020PADMAJA J.A.SRelativeBuy5.0K₹35.1L702.805.0K → 10.0K0.01%+0.01 pp7(2)told 27 Aug 2020
24 Aug 2020PADMAJA J.A.SRelativeBuy5.0K₹34.3L685.74— → 5.0K0.00%7(2)told 24 Aug 2020
4 Jul 2020PADMA KUMAR REmployeeBuy10.0K₹47.0L470.311.22L → 1.32L0.10%+0.01 pp7(2)told 2 Jul 2020

SEBI insider-trading disclosures, equity only. Dated by the day NSE broadcast them; the trade itself is often weeks earlier. The figures count promoters, directors and KMPs buying or selling on the exchange — not ESOPs, gifts, transfers within the promoter group or pledges. Stake is the holding after, as filed; the change beneath it scales that by the share counts before and after. Regulation is the PIT clause cited, and “told” the day the insider informed the company.

How the insider figures are countedPromoters buying in the open market, market-wideEvery stock on this session

Bulk & block deals · 11 Nov 2026

CSV
12 of 19 deals
By year
DateDealClientQuantityPriceValue
11 Nov 2026Sell · block, also bulkJASTI FAMILY TRUST21.00L449.50₹94.4Cr
11 Nov 2026Buy · block, also bulkJASUB PROPERTY HOLDINGS LLP21.00L449.50₹94.4Cr
9 Nov 2026Sell · block, also bulkJASTI FAMILY TRUST30.00L430.00₹129.0Cr
9 Nov 2026Buy · block, also bulkJASUB PROPERTY HOLDINGS LLP30.00L430.00₹129.0Cr
23 Feb 2026Sell · block, also bulkJASTI FAMILY TRUST77.00L306.00₹235.6Cr
23 Feb 2026Buy · block, also bulkJASUB PROPERTY HOLDINGS LLP77.00L306.00₹235.6Cr
18 Feb 2026Sell · block, also bulkJASTI FAMILY TRUST70.00L309.00₹216.3Cr
18 Feb 2026Buy · block, also bulkJASUB PROPERTY HOLDINGS LLP70.00L309.00₹216.3Cr
18 Sept 2025Sell · bulkJUSMIRAL HOLDINGS LIMITED3.41Cr906.00₹3,093.8Cr
18 Sept 2025Buy · bulkHDFC MUTUAL FUND37.18L906.00₹336.8Cr
18 Sept 2025Buy · bulkSBI MUTUAL FUND26.83L905.71₹243.0Cr
1 Mar 2024Sell · bulkAMANSA HOLDINGS PRIVATE LIMITED · as SUVENPHAR31.27L689.19₹215.5Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026
  • Zero EPS (4 quarters) · since 16 Nov 2026 — Zero EPS over the last four quarters.
  • Encumbrance > 50% · since 22 Aug 2025 — More than half of the promoters’ holding is encumbered.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
By year
 Q2 FY24Q3 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26RQ3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue from operations231.1219.8230.7257.7307.2402.0549.3555.6544.6619.1422.3476.7
Other income19.814.318.214.115.710.614.215.66.2(1.8)12.312.4
Total income250.9234.2248.8271.8322.9412.6563.5571.2550.7617.3434.5489.1
Total expenses145.5168.7165.8172.3213.1361.0492.6487.4505.3580.9477.4499.8
└ Finance costs0.51.31.61.73.35.810.28.89.19.26.78.4
└ Depreciation11.912.813.417.020.426.845.144.046.951.249.550.2
Profit before tax105.465.583.199.5109.751.662.883.840.619.9(42.9)(10.8)
Tax expense25.818.722.317.526.412.916.417.411.611.62.3(13.0)
Net profit79.646.860.882.083.338.746.466.429.08.3(45.2)2.3
EPS3.131.842.393.233.261.651.281.940.960.51-0.630.40
Net margin34.44%21.27%26.34%31.81%27.12%9.63%8.45%11.95%5.33%1.34%-10.70%0.48%
PBT margin45.62%29.78%36.01%38.61%35.73%12.84%11.43%15.08%7.46%3.22%-10.15%-2.26%
Tax rate24.52%28.59%26.87%17.61%24.10%24.94%26.07%20.75%28.52%58.26%——

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 6 Nov 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 H1 FY23FY23H1 FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets1,806.01,965.72,119.82,505.63,031.85,568.55,729.65,680.2
Current assets922.51,011.01,169.11,146.5853.31,809.01,796.31,716.7
└ Cash & equivalents66.664.857.636.885.482.649.198.6
└ Other bank balances18.43.23.25.33.314.810.59.2
└ Current investments327.3418.9652.9619.1191.7303.1266.3185.1
└ Trade receivables111.2110.9136.9184.0284.4589.7681.0469.0
└ Inventories318.3312.8271.5215.5166.6592.9562.2734.3
Total equity1,503.11,735.21,935.42,028.41,840.63,924.64,033.83,986.9
└ Attributable to owners1,503.11,735.21,935.41,978.31,696.63,787.73,911.33,912.2
└ Non-controlling interest———50.1144.1136.9122.574.7
└ Share capital25.525.525.525.525.538.338.338.3
Borrowings90.669.249.19.178.1221.5169.7227.7
└ Current70.464.649.11.971.9148.7119.2199.6
└ Non-current20.24.60.07.16.272.950.528.1
Trade payables85.665.242.665.380.2313.3284.6364.3
Current liabilities216.5158.8112.4238.1365.2631.4645.9865.4
Total liabilities303.0230.6184.4477.11,191.11,643.91,695.81,693.3
Net debt(321.7)(417.8)(664.5)(652.1)(202.3)(179.0)(156.3)(65.2)
Debt / equity0.060.040.030.000.040.060.040.06
Current ratio4.266.3710.404.812.342.872.781.98

Cash flow, year to date

 H1 FY23FY23H1 FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow416.3450.9252.3177.7288.2261.1368.3188.1
└ Capex(193.7)(285.8)(26.8)0.0(155.7)(89.7)(219.9)(108.0)
Free cash flow222.6165.1225.5177.7132.5171.4148.480.1
Investing cash flow(183.3)(194.8)(237.9)(142.3)(255.3)(194.1)(254.6)(46.7)
Financing cash flow(211.0)(235.8)(21.6)(45.8)3.3(82.9)(165.2)(92.5)
└ Dividends paid(203.7)(203.7)0.00.00.00.00.00.0
└ Buybacks0.00.00.00.00.00.00.00.0
Net change in cash22.020.2(7.2)(10.4)36.2(15.8)(51.4)49.5

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

COHANCE at a glance

  • COHANCE closed at ₹462.3 on 20 Nov 2026, +0.62% on the day, -24.9% over one year, 25.9% below its 52-week high of ₹624.
  • Delivery was 46.2% of traded quantity on 20 Nov 2026, the 25th percentile of its own 1,656 sessions with a reading (20-session average 40.7%, 1-year average 44.0%).
  • Market capitalisation is ₹17,687 crore at a trailing P/E of 373.4 (trailing EPS ₹1.24).
  • Q2 FY27 results (consolidated, filed 6 Nov 2026): revenue ₹477 crore (-14.2% year on year), net profit ₹2 crore (-96.6%); the price moved +1.9% on the first session after.
  • Promoters held 57.48% at 30 Sept 2026, down 0.01 percentage points on the previous filing, with 94.56% of promoter shares pledged.
  • Q3 FY27 results are expected between 6 Feb 2027 and 13 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE03QK01018
SeriesEQ
Listed9 Mar 2020
Former symbolsSUVENPHAR (until 19 May 2025)
Former namesSuven Pharmaceuticals Limited (until 19 May 2025)
NSE market cap · 17 Nov 2026₹17,278 Cr
Free-float market cap (NSE)₹7,328 Cr
Shares outstanding (NSE)38.26Cr
History from9 Mar 2020
Sessions1,662
Turnover rank#602

Sector history

  1. to 16 Aug 2026Index industry · Healthcare
  2. from 16 Aug 2026Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

NSE’s own classification, by the snapshot it changed on.

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.